1. Home
  2. DOGZ vs PBYI Comparison

DOGZ vs PBYI Comparison

Compare DOGZ & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DOGZ
  • PBYI
  • Stock Information
  • Founded
  • DOGZ 2003
  • PBYI 2010
  • Country
  • DOGZ China
  • PBYI United States
  • Employees
  • DOGZ N/A
  • PBYI N/A
  • Industry
  • DOGZ Miscellaneous manufacturing industries
  • PBYI Biotechnology: Pharmaceutical Preparations
  • Sector
  • DOGZ Consumer Discretionary
  • PBYI Health Care
  • Exchange
  • DOGZ Nasdaq
  • PBYI Nasdaq
  • Market Cap
  • DOGZ 146.2M
  • PBYI 171.7M
  • IPO Year
  • DOGZ 2017
  • PBYI N/A
  • Fundamental
  • Price
  • DOGZ $11.58
  • PBYI $4.56
  • Analyst Decision
  • DOGZ
  • PBYI Strong Buy
  • Analyst Count
  • DOGZ 0
  • PBYI 1
  • Target Price
  • DOGZ N/A
  • PBYI $7.00
  • AVG Volume (30 Days)
  • DOGZ 576.3K
  • PBYI 980.5K
  • Earning Date
  • DOGZ 10-20-2025
  • PBYI 11-06-2025
  • Dividend Yield
  • DOGZ N/A
  • PBYI N/A
  • EPS Growth
  • DOGZ N/A
  • PBYI 434.29
  • EPS
  • DOGZ N/A
  • PBYI 0.97
  • Revenue
  • DOGZ $20,258,926.00
  • PBYI $238,062,000.00
  • Revenue This Year
  • DOGZ N/A
  • PBYI N/A
  • Revenue Next Year
  • DOGZ N/A
  • PBYI N/A
  • P/E Ratio
  • DOGZ N/A
  • PBYI $4.75
  • Revenue Growth
  • DOGZ 46.16
  • PBYI 8.63
  • 52 Week Low
  • DOGZ $6.81
  • PBYI $2.25
  • 52 Week High
  • DOGZ $58.50
  • PBYI $6.07
  • Technical
  • Relative Strength Index (RSI)
  • DOGZ 49.92
  • PBYI 47.28
  • Support Level
  • DOGZ $9.34
  • PBYI $4.93
  • Resistance Level
  • DOGZ $12.15
  • PBYI $5.22
  • Average True Range (ATR)
  • DOGZ 1.75
  • PBYI 0.32
  • MACD
  • DOGZ -0.13
  • PBYI -0.10
  • Stochastic Oscillator
  • DOGZ 50.11
  • PBYI 7.37

About DOGZ Dogness (International) Corporation

Dogness (International) Corp designs, manufactures pet products, including leashes and smart products, and lanyards. The company designs, processes, and manufactures fashionable and high-quality leashes, collars, and harnesses to complement cats' and dogs' appearances, as well as intelligent pet products. The company also provides dyeing services to external customers, as well as pet grooming services. The dyeing service is to utilize the existing production capacity and the pet grooming service is immaterial. Geographically, it generates maximum revenue from Mainland China and also has a presence in the United States, Europe, Australia, Canada, Central, and South America, Japan, and other Asian countries and regions.

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

Share on Social Networks: